David Spika, of WHG Funds, and Bill Smead, of Smead Capital Mgmt., share their investment strategies and stock picks.
Insight on why regional banks could be major players in the market, with Peyton Patterson, NewAlliance Bancshares, Inc. chairman/president/C...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr. Steven Nissen, chairman of the Department of Cardiovascular Medicine at ...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Barbara Ryan, pharma analyst at Deutsche Bank Securities, shares her reactio...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Posts |
COMPANY : Mylan Laboratories Inc
20 Nov 2009
Here's our Fast Money Final Trade... Read More
17 Nov 2009
Stocks opened lower on Tuesday, after a sharp rally in the prior session... Read More
12 Nov 2009
The Dollar Index is up for a second day in a row on Treasury Secretary Geithner's comments that the administration is committed to a stronger dollar.... Read More
9 Nov 2009
This weekend, the US House of Representatives passed its version of health care reform and now awaits a version from the Senate.... Read More
8 Oct 2009
Let’s say your stock hits a 52-week high... Read More
News |
COMPANY : Mylan Laboratories Inc
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
